305 COLLEGE ROAD EAST, PRINCETON, NJ
Annual Report to Security Holders
Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Third Quarter 2025 Financial Results and Provides Business Update
Provides DrugSorb-ATR Regulatory Update
Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Reports Second Quarter 2025 Financial Results and Provides Business Update.
Q1
Amended Annual Report
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Free Writing Prospectus
Correspondence